| Literature DB >> 29757961 |
Tian Guan1,2, Xiangnan Wang3,4, Dongmei Li5,6, Yilong Zhang7,8, Yonghong He9,10, Lixuan Shi11,12, Yiqing Liu13,14, Yuxuan Yang15,16, Yang Xu17,18, Rui Cui19.
Abstract
A phase-sensitive weak measurement biosensor was proposed for the detection of carcinoembryonic antigen (CEA), one common category of tumor markers. The total internal reflection (TIR) at the interface of the prism without precious metal coating was exploited to introduce the phase delay between horizontal and vertical polarizations, which can be determined through the central wavelength shift of output spectra for the sensing of the refractive index of the sample. In the weak measurement analysis, the specific binding reaction of tumor markers with a refractive index change on the surface of the prism can be monitored in real time through the central wavelength shift. With the specific absorption measurement, the feasibility of this weak measurement-based biosensor was experimentally demonstrated. We provide a low cost and convenient approach for tumor marker detection.Entities:
Keywords: optical biosensor; phase measurement; total internal reflection; weak measurement
Mesh:
Substances:
Year: 2018 PMID: 29757961 PMCID: PMC5982534 DOI: 10.3390/s18051550
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1The schematic diagram of the weak measurement system. SLD: super luminescent diode central at 830 nm with a bandwidth of 50 nm. GF: Gaussian filter with a bandwidth of 20 nm. QWP: quarter wave plate.
Figure 2The central wavelength shifts with respect to the dip angle χ. The solid line is the theoretical expectation. The square dots are the experimental data; the standard deviation of experimental data is too small to be distinguished.
Figure 3(a) The photograph of the real system. SLD: super luminescent diode central at 840 nm; GF: Gaussian filter with a bandwidth of 20 nm; Pre: pre-selection polarizer; QWP: quarter wave plate; post: post-selection polarizer. (b) The experimentally detected two-peak spectrum.
Figure 4Experimental result for diluted glucose resolutions, (a) The result of the weak measurement-based system, inset: shifts measuring a 10 g/L glucose solution in 100 s; (b) The result of the angular spectra SPR based system. The error bar was obtained by repeating the measurements three times, inset: shifts measuring a 10 g/L glucose solution in 100 s.
Figure 5The schematic diagram of the detection process of CEA. Blocking reagent: protein-free blocking buffer, which can eliminate non-specific binding sites to avoid the non-specific adsorption.
Figure 6The result of detected process of CEA. DPA: dopamine solution; PBS: phosphate buffered saline solution; anti-CEA: CEA antibody; blocking reagent: protein-free blocking buffer.
Figure 7The central wavelength shifts of CEA and the two controlled trials. Error bars represent the standard deviations for three repeating experiments.
Figure 8(a) The experimental result of CEA in different concentration: 50 μg/mL, 25 μg/mL, 15 μg/mL, 10 μg/mL, 5 μg/mL, and 0 μg/mL (water). Error bars represent the standard deviations for three repeating experiments. (b) The sensorgrams obtained with the different CEA concentrations reaction reaches equilibrium, and experimental data were collected over the course of 20 min.